typical muscle loss with weight loss) Greater improvements in insulin sensitivity and lipid profiles Immune Optimization (Thymosin Alpha-1) Target Patient Profile: Chronic viral infections (EBV, Lyme, long COVID) Recurrent infections suggesting immune deficiency Cancer patients during or post-treatment Autoimmune conditions requiring immune modulation Recovery from severe illness or major surgery Treatment Protocol: Baseline: Complete immune panel including lymphocyte subsets (CD4, CD8, NK cells), inflammatory markers Dosing: 1.6 mg subcutaneously 2-3 times weekly for chronic support
[43] RG3 and VIP are commonly incorporated in the treatment of Lyme and toxic mold syndrome (see my article on mold toxicity for more information on my treatment philosophy)
Whether youre looking for a weekly energy boost, preparing for travel, or simply want to look and feel your best, our expert team can recommend a tailored blend to suit your needs
CAS 62568-57-4) was isolated in 1977 by Schoenenberger, Monnier and colleagues at the University of Basel from the cerebral venous blood of rabbits subjected to hypnogenic electrical stimulation of the intralaminar thalamus, and named for the slow-wave (delta) EEG activity it appeared to enhance after intraventricular infusion in recipient rabbits (Schoenenberger & Monnier, 1977)
Unlike GLP-1 agonists, 5-amino-1mq does not work through appetite suppression
